ArticleLung cancer (Amsterdam, Netherlands)2020

Identification of novel epigenetic abnormalities as sputum biomarkers for lung cancer risk among smokers and COPD patients.

Mathewos Tessema et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.